Physician profile
Carolyn Dodds Fields
NPI 1144217118
$1,432.72
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $702.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $358.42 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $210.36 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $185.79 | 2019-2020 | |
| Amgen INC. | $85.96 | 2019 | |
| Glaxosmithkline, LLC. | $74.16 | 2019-2020 | |
| Lilly USA, LLC | $64.01 | 2019-2020 | |
| Astellas Pharma US INC | $61.64 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $60.45 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $47.29 | 2019-2020 | |
| Covidien LP | $46.25 | 2019 | |
| Pfizer INC. | $37.02 | 2019-2020 | |
| Amarin Pharma, INC. | $33.09 | 2020 | |
| Boston Scientific Corporation | $30.58 | 2019 | |
| Alexion Pharmaceuticals, INC. | $18.30 | 2020 | |
| Gilead Sciences, INC. | $17.55 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.17 | 2020 | |
| Daiichi Sankyo INC. | $14.15 | 2019 | |
| Sanofi Pasteur INC. | $14.08 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.17 | 2020 | |
| Abbvie INC. | $12.36 | 2019 | |
| Allergan, INC. | $12.21 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $10.89 | 2019 | |
| Assertio Therapeutics, INC. | $10.82 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carolyn Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.